摘要
Ⅱ型糖尿病是非胰岛素依赖性糖尿病,近年来我国糖尿病的患病率有明显上升趋势,其中以Ⅱ型糖尿病为主,口服降糖药可以减少注射胰岛素带来的用药痛苦以及不便。但是同时目前应用的口服降糖药还存在药效持续时间短、生物利用度不高等问题。因此开发新的口服降糖药物剂型,可以进一步提高药物疗效,降低药物的不良反应。本文就口服降糖药物的应用及新型制剂研究进展做一综述。
typeⅡdiabetes is non insulin dependent diabetes,the prevalence of typeⅡdiabetes is rising in China. oral hypoglycemic drugs provides a new approach for patients with typeⅡdiabetes. It can reduce the pain and inconvenience caused by insulin injections. oral hypoglycemic drug has become a new research focus,but at the same time,the current dosage of oral hypoglycemic drugs also has some problems,for example,efficacy of short duration,bioavailability problem is not high and so on. The development of oral hypoglycemic drugs new dosage can further improve efficacy,and reduce the adverse reactions of drugs. This article makes a summary on the progress in the application of oral hypoglycemic drugs and new preparation research.
出处
《天津药学》
2015年第1期58-60,共3页
Tianjin Pharmacy
关键词
Ⅱ型糖尿病
口服
降糖药物
typeⅡ diabetes
oral
hypoglycemic drugs
